10-Year hip implant study ends early – what we know

NCT ID NCT04193163

Terminated Knowledge-focused Sponsor: FH ORTHO Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study followed 10 people who received an ESOP 2 hip stem during total hip replacement. Researchers wanted to see how safe and effective the device was over 10 years in real-life use. The study was stopped early, so the full long-term picture is incomplete.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: ESOP 2 cementless femoral stem (hip prosthesis device)
What this could lead to: If successful, this study could confirm that the ESOP 2 stem is safe and works well over many years for hip replacement patients.
What could go wrong: This was a very small study (10 people) that ended early, so results may not apply to all patients. Long-term data is limited.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FEMORAL NECK FRACTURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

femoral neck fracture hip fracture

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIP DISEASE HIP FRACTURES

Contacts and locations

Locations

CH Pasteur

Colmar, 68024, France
CH Raymond POINCARE

Garches, 92380, France
CH de Haguenau

Haguenau, 67504, France
Clinique Tivoli Ducos

Bordeaux, 33000, France
Clinique du Val d'Ouest

Écully, 69130, France
Groupe Hospitalier Pitié-Salpêtrière

Paris, 75651, France
Nouvelle Clinique Bel-Air

Bordeaux, 33000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.